Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US2561352038

SecurityRDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Macquarie Group Ltd closes position in RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)

On February 13, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 0 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) (US:RDY) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 13,831 shares of Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock). The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F DR REDDYS LABS ADR 256135203 0 -100.00 0
2025-11-13 2025-09-30 13F DR REDDYS LABS ADR 256135203 13,831 7,510 118.81 193 103.16 0.0002
2025-08-14 2025-06-30 13F DR REDDYS LABS ADR 256135203 6,321 0 0.00 95 14.46 0.0001
2025-08-14 2025-03-31 13F/A-1 DR REDDYS LABS ADR 256135203 6,321 2,430 62.45 83 36.07 0.0001
2025-05-15 2025-03-31 13F DR REDDYS LABS ADR 256135203 6,321 2,430 83 0.0001
2025-02-14 2024-12-31 13F DR REDDYS LABS ADR 256135203 3,891 3,501 897.69 61 96.77 0.0001
2024-11-14 2024-09-30 13F DR REDDYS LABS ADR 256135203 390 390 31 0.0000
2022-11-14 2022-09-30 13F DR REDDYS LABS ADR 256135203 0 -401 -100.00 0 -100.00
2022-08-17 2022-06-30 13F/A-1 DR REDDYS LABS ADR 256135203 401 -504 -55.69 22 -56.00 0.0000
2022-08-15 2022-06-30 13F DR REDDYS LABS ADR 256135203 401 -504 22 0.0000
2022-05-16 2022-03-31 13F DR REDDYS LABS ADR 256135203 905 905 50 0.0000
2021-02-16 2020-12-31 13F DR REDDYS LABS ADR 256135203 0 -104,132 -100.00 0 -100.00
2020-11-13 2020-09-30 13F DR REDDYS LABS ADR 256135203 104,132 0 0.00 7,243 31.21 0.0123
2020-08-11 2020-06-30 13F DR REDDYS LABS ADR 256135203 104,132 -105,367 -50.29 5,520 -34.67 0.0095
2020-05-15 2020-03-31 13F DR REDDYS LABS ADR 256135203 209,499 -115,084 -35.46 8,449 -35.86 0.0174
2020-03-18 2019-12-31 13F/A-2 DR REDDYS LABS ADR 256135203 324,583 0 0.00 13,172 7.11 0.0188
2020-02-28 2019-12-31 13F/A-1 DR REDDYS LABS ADR 256135203 324,583 0 13,172 0.0190
2020-02-14 2019-12-31 13F DR REDDYS LABS ADR 256135203 324,583 0 13,172 16,529.7437
2019-11-14 2019-09-30 13F DR REDDYS LABS ADR 256135203 324,583 -50,660 -13.50 12,298 -12.53 0.0206
2019-11-06 2019-06-30 13F/A-2 DR REDDYS LABS ADR 256135203 375,243 19,000 5.33 14,060 -2.55 0.0237
2019-09-24 2019-06-30 13F/A-1 DR REDDYS LABS ADR 256135203 375,243 0 14,060 0.0239
2019-08-14 2019-06-30 13F DR REDDYS LABS ADR 256135203 375,243 19,000 14,060
2019-05-15 2019-03-31 13F DR REDDYS LABS ADR 256135203 356,243 2,500 0.71 14,428 8.19 0.0246
2019-02-15 2018-12-31 13F DR REDDYS LABS ADR 256135203 353,743 143,743 68.45 13,336 83.54 0.0258
2018-11-15 2018-09-30 13F DR REDDYS LABS ADR 256135203 210,000 210,000 7,266 0.0118
2016-05-16 2016-03-31 13F Dr. Reddy's Laboratories ADR 256135203 0 -35 -100.00 0 -100.00
2016-02-16 2015-12-31 13F Dr. Reddy's Laboratories ADR 256135203 35 -7,682 -99.55 2 -99.59 0.0000
2015-11-16 2015-09-30 13F Dr. Reddy's Laboratories ADR 256135203 7,717 740 10.61 493 27.72 0.0011
2015-08-21 2015-06-30 13F/A-1 Dr. Reddy's Laboratories ADR 256135203 6,977 123 1.79 386 -1.28 0.0008
2015-08-14 2015-06-30 13F Dr. Reddy's Laboratories ADR 256135203 6,977 386
2015-05-18 2015-03-31 13F Dr. Reddy's Laboratories ADR 256135203 6,854 -8,459 -55.24 391 -49.42 0.0008
2015-02-17 2014-12-31 13F Dr. Reddy's Laboratories ADR 256135203 15,313 -8,584 -35.92 773 -38.46 0.0016
2014-11-14 2014-09-30 13F Dr. Reddy's Laboratories ADR 256135203 23,897 12,188 104.09 1,256 148.71 0.0027
2014-08-14 2014-06-30 13F Dr. Reddy's Laboratories COMMON 256135203 11,709 -2,612 -18.24 505 -19.71 0.0011
2014-05-15 2014-03-31 13F Dr. Reddy's Laboratories Common Stock 256135203 14,321 -3,742 -20.72 629 -15.11 0.0011
2014-02-14 2013-12-31 13F Dr. Reddy's Laboratories Common Stock 256135203 18,063 6,904 61.87 741 75.59 0.0013
2013-11-14 2013-09-30 13F DR REDDYS LABS LTD ADR Common Stock 256135203 11,159 -1,327 -10.63 422 -10.59 0.0008
2013-08-16 2013-06-30 13F/A-1 DR REDDYS LABS LTD ADR Common 256135203 12,486 12,486 472 0.0010
2013-08-14 2013-06-30 13F DR REDDYS LABS LTD ADR Common 256135203 12,486 472
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.